Evidence map›Paper›PMID 29067342›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2017

The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease.

Kevin G Burfeind, Charles F Murchison, Shawn K Westaway, Matthew J Simon, Deniz Erten-Lyons, Jeffrey A Kaye, Joseph F Quinn, Jeffrey J Iliff

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Cerebral small vessel disease: The impact of glymphopathy and sleep disorders.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025
    Review
  14. Article
  15. Article
  16. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kevin G BurfeindDepartment of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, USA.
Charles F MurchisonDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Shawn K WestawayDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Matthew J SimonDepartment of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, USA.
Deniz Erten-LyonsDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Jeffrey A KayeDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Joseph F QuinnDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Jeffrey J IliffDepartment of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, USA.
Oregon Health & Science University · US

Funding

Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI DODGE, HIROKO HAYAMA · 1990 to 2019
$27.7M
Defining the role of age-related glymphatic pathway impairment in amyloid beta plaque depositionR01AG054456 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI ILIFF, JEFFREY J · 2017 to 2021
$1.8M
Role of perivascular aquaporin-4 polarization in post-traumatic neurodegenerationR01NS089709 · NINDS · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI ILIFF, JEFFREY J · 2015 to 2019
$1.7M
NIA NIH HHS P30 AG008017NIA NIH HHS R01 AG054456NINDS NIH HHS R01 NS089709
6 · The paper itself

Abstract

introductionThe glymphatic system is a brain-wide perivascular network that facilitates clearance of proteins, including amyloid β, from the brain interstitium through the perivascular exchange of cerebrospinal fluid and interstitial fluid. The astrocytic water channel aquaporin-4 (AQP4) is required for glymphatic system function, and impairment of glymphatic function in the aging brain is associated with altered AQP4 expression and localization. In human cortical tissue, alterations in AQP4 expression and localization are associated with Alzheimer's disease (AD) status and pathology. Although this suggests a potential role for AQP4 in the development or progression of AD, the relationship between of naturally occurring variants in the human

methodsUsing data from several longitudinal aging cohorts, we investigated the association between five

resultsNone of the five SNPs were associated with different rates of AD diagnosis, age of dementia onset in trial subjects. No association between DISCUSSION: These results provide the first evidence that variations in the

Indexed as

Alzheimer's diseaseAmyloid βAquaporin-4Cognitive declineCohort studyGeneticsGlymphatic system

Identifiers

PMID29067342
PMCPMC5651426
OpenAlexW2619053878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.